Publicacións en colaboración con investigadores/as de University of Manchester (34)

2023

  1. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 9, pp. 2803-2811

2020

  1. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1043-1057

  2. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1023-1042

  3. Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1058-1068

  4. International severe asthma registry (ISAR): Protocol for a global registry

    BMC Medical Research Methodology, Vol. 20, Núm. 1

2019

  1. Development of the International Severe Asthma Registry (ISAR): A Modified Delphi Study

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 2, pp. 578-588.e2

2015

  1. A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility

    American Journal of Human Genetics, Vol. 96, Núm. 4, pp. 565-580

2011

  1. Interleukin-1 beta gene polymorphism in patients with biopsy-proven erythema nodosum

    Clinical and Experimental Rheumatology

2010

  1. Interleukin-1 receptor antagonist gene polymorphism in patients with biopsy-proven erythema nodosum

    Clinical and Experimental Rheumatology

2009

  1. Regulated upon activation normal T-cell expressed and secreted (RANTES) and epithelial cell-derived neutrophil-activating peptide (ENA-78) gene polymorphisms in patients with biopsy-proven erythema nodosum

    Clinical and Experimental Rheumatology

2008

  1. Contribution of HLA-DRB1 shared epitope alleles and chronic inflammation to the increased incidence of cardiovascular disease in rheumatoid arthritis: Comment on the article by Farragher et al.

    Arthritis and Rheumatism

  2. Interleukin-6 promoter polymorphism at position - 174 in biopsy-proven patients with erythema nodosum from a defined population

    Clinical and Experimental Rheumatology

2007

  1. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis

    Arthritis Care and Research, Vol. 57, Núm. 1, pp. 125-132

  2. Lack of association between interleukin-6 promoter polymorphism at position -174 and Henoch-Schönlein purpura

    Clinical and Experimental Rheumatology, Vol. 25, Núm. 1 SUPPL. 44

  3. Persistent Chronic Inflammation Contributes to the Development of Cancer in Patients with Rheumatoid Arthritis from a Defined Population of Northwestern Spain

    Seminars in Arthritis and Rheumatism, Vol. 37, Núm. 1, pp. 31-38

2006

  1. Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis

    Clinical and Experimental Rheumatology, Vol. 24, Núm. 5, pp. 576-579

2005

  1. Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Schönlein purpura in Northwestern Spain

    Journal of Rheumatology, Vol. 32, Núm. 6, pp. 1081-1085

  2. Lack of association between macrophage migration inhibitory factor gene polymorphism and giant cell arteritis

    Journal of Rheumatology, Vol. 32, Núm. 1, pp. 74-76

2004

  1. E-selectin polymorphism in erythema nodosum secondary to sarcoidosis

    Clinical and Experimental Rheumatology, Vol. 22, Núm. 2, pp. 230-232

  2. Echocardiographic and Doppler Findings in Long-Term Treated Rheumatoid Arthritis Patients without Clinically Evident Cardiovascular Disease

    Seminars in Arthritis and Rheumatism, Vol. 33, Núm. 4, pp. 231-238